About This Trial
Phase III Clinical Study to Evaluate the Safety and Efficacy of Elagolix in combination with Norethindrone Acetate or Estradiol/Norethindrone Acetate in Participants With Moderate to Severe Endometriosis-Associated Pain
- Status: Enrolling now
- Location: Miami Valley Hospital
- Study type: Interventional
- Ages eligible for study: 18 to 49 years
- Genders eligible for study: Female
- Principal Investigator: Dr. Gregory Talbot
- For more information about this study, visit ClinicalTrials.gov: NCT03213457
Contact Us
If you would like information about participating in this study, contact:
Dawn Shields, BS
937-208-3689
dashields@premierhealth.com